Unique
lindenane sesquiterpenoid dimers from Chloranthecae spp. were recently identified with promising in vitro antiplasmodial activity and potentially novel mechanisms of action.
To gain mechanistic insights to this new class of natural products, in vitro selection of Plasmodium falciparum resistance to the most active antiplasmodial compound, chlorajaponilide
C, was explored. In all selected resistant clones, the half-maximal
effective concentration (EC50) of chlorajaponilide C increased
>250-fold, and whole genome sequencing revealed mutations in the
recently
discovered P. falciparum prodrug activation
and resistance esterase (PfPARE). Chlorajaponilide C was highly potent
(mean EC50 = 1.6 nM, n = 34) against fresh
Ugandan P. falciparum isolates. The analysis
of the structure-resistance relationships revealed that in
vitro potency of a subset of lindenane sesquiterpenoid dimers
was not mediated by PfPARE mutations. Thus, chlorajaponilide C, but
not some related compounds, required parasite esterase activity for in vitro potency, and those compounds serve as the foundation
for development of potent and selective antimalarials.